Targeting transposable elements in cancer: developments and opportunities
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-09 · 1879 (5) · 189143
DOI: 10.1016/j.bbcan.2024.189143 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-09. Verfasst von Zi-Yu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 2…. Hauptthemen laut MEDLINE: Neoplasms, DNA Transposable Elements. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 376 Literaturangaben. Gefördert von: Shanghai Municipal Natural Science Foundation.
Abstract (Originalsprache)
Transposable elements (TEs), comprising nearly 50% of the human genome, have transitioned from being perceived as "genomic junk" to key players in cancer progression. Contemporary research links TE regulatory disruptions with cancer development, underscoring their therapeutic potential. Advances in long-read sequencing, computational analytics, single-cell sequencing, proteomics, and CRISPR-Cas9 technologies have enriched our understanding of TEs' clinical implications, notably their impact on genome architecture, gene regulation, and evolutionary processes. In cancer, TEs, including long interspersed element-1 (LINE-1), Alus, and long terminal repeat (LTR) elements, demonstrate altered patterns, influencing both tumorigenic and tumor-suppressive mechanisms. TE-derived nucleic acids and tumor antigens play critical roles in tumor immunity, bridging innate and adaptive responses. Given their central role in oncology, TE-targeted therapies, particularly through reverse transcriptase inhibitors and epigenetic modulators, represent a novel avenue in cancer treatment. Combining these TE-focused strategies with existing chemotherapy or immunotherapy regimens could enhance efficacy and offer a new dimension in cancer treatment. This review delves into recent TE detection advancements, explores their multifaceted roles in tumorigenesis and immune regulation, discusses emerging diagnostic and therapeutic approaches centered on TEs, and anticipates future directions in cancer research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: yizhoujiang@fudan.edu.cn.
Förderung
- Shanghai Municipal Natural Science Foundation
Zitieren
APA
Wang, Z. Y., Ge, L. P., Ouyang, Y., Jin, X., & Jiang, Y. Z. (2024). Targeting transposable elements in cancer: developments and opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(5), 189143. https://doi.org/10.1016/j.bbcan.2024.189143
Vancouver
Wang ZY, Ge LP, Ouyang Y, Jin X, Jiang YZ. Targeting transposable elements in cancer: developments and opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(5):189143. doi:10.1016/j.bbcan.2024.189143
BibTeX
@article{Wang2024,
author = {Wang, Zi-Yu and Ge, Li-Ping and Ouyang, Yang and Jin, Xi and Jiang, Yi-Zhou},
title = {Targeting transposable elements in cancer: developments and opportunities},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
volume = {1879},
number = {5},
pages = {189143},
doi = {10.1016/j.bbcan.2024.189143}
}
EUVIMED